Key facts
- This page summarizes Sam Eldessouky's Form 4 filing for Bausch & Lomb Corp (BLCO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Feb 2025, 16:25.
Sam Eldessouky - 26 Feb 2025 Form 4 Insider Report for Bausch & Lomb Corp (BLCO)
- Reporting relationship
- EVP and CFO
- Issuer ticker
- BLCO
- Reported as of
- 26 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2025, 16:25:14 UTC
- Prior SEC filing
- 26 Dec 2024
- Next SEC filing
- 28 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Debra E. Levin, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sam Eldessouky filed Form 4 for Bausch & Lomb Corp (BLCO) on 28 Feb 2025.
Change
- Previous filing in this sequence was filed on 26 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLCO
transaction
Common Shares, No Par Value
Award
- Transaction value
- $0
- Shares
- +59,459
- Change %
- +27%
- Price
- $0.000000
- Shares after
- 282,295
- Date
- 26 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BLCO
transaction
Derivative
Non-Qualified Stock Options (right to purchase)
Award
- Transaction value
- $0
- Shares
- +141,630
- Change %
- Price
- $0.000000
- Shares after
- 141,630
- Date
- 26 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 141,630
- Exercise price
- $15.86
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.
Footnote F2
Reflects the grant of stock options to purchase common shares under the Plan.
Footnote F3
The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.
Footnote F4
The stock options will expire on the tenth anniversary of the grant date.